tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Technical Analysis

Compare
348 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is 0.28, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 14.58, while Keros Therapeutics’s (KROS) share price is $15.52, making it a Buy.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 14.29, while Keros Therapeutics’s (KROS) share price is $15.52, making it a Buy.

Keros Therapeutics (KROS) Pivot Points

Aug 29, 2025, 07:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.11
14.34
14.63
14.85
15.14
15.37
15.65
Fibonacci
14.34
14.54
14.66
14.85
15.05
15.17
15.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Aug 29, 2025, 07:39 AM
Period
Simple
Exponential
MA5
15.18Buy
15.09Buy
MA10
14.81Buy
14.84Buy
MA20
14.41Buy
14.58Buy
MA50
14.13Buy
14.29Buy
MA100
13.92Buy
15.57Sell
MA200
19.08Sell
23.70Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 14.84, while Keros Therapeutics’s (KROS) share price is $15.52, making it a Buy.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 15.57, while Keros Therapeutics’s (KROS) share price is $15.52, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $15.52 and Keros Therapeutics’s (KROS) 50-day simple moving average is 14.13, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $15.52 and Keros Therapeutics’s (KROS) 100-day simple moving average is 13.92, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $15.52 and Keros Therapeutics’s (KROS) 200-day simple moving average is 19.08, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Aug 29, 2025, 07:39 AM
Name
Value
Implied Action
RSI (14)
62.15
Neutral
STOCH (9,6)
62.21
Neutral
STOCHRSI (14)
71.84
Neutral
MACD (12,26)
0.28
Sell
ADX (14)
23.44
Neutral
Williams %R
-11.76
Sell
CCI (14)
157.55
Sell
ATR (14)
0.64
-
Ultimate Oscillator
51.48
Neutral
ROC
16.17
Buy
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 62.15, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 23.44, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is 157.55, creating a Sell signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is 16.17, creating a Buy signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Buy.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 62.15, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is 0.28, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 15.18, which suggests KROS is a Buy.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 14.41, which suggests KROS is a Buy.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 14.13, which suggests KROS is a Buy.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 19.08, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -11.76, which suggests KROS is a Sell.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is 157.55, which suggests KROS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis